Results 31 to 40 of about 88,056 (266)
Journal of Infection and Public Health, 2023 Background: Institutions must have access to antibiograms to monitor changes in antimicrobial resistance and direct empirical antibiotic therapy. The first facility-specific cumulative antibiogram was launched in the ICU in 2019.
Essamedin M. Negm +12 more
doaj +1 more source
Prescribing Profile at a Pharmacy in Yogyakarta During the Period August-October 2024 [PDF]
E3S Web of ConferencesA drug prescription profile is a list of drugs prescribed or required by a service and is one of the bases for preparing a pharmacy's drug planning. This study aims to ascertain the prescribing habits of a Yogyakarta pharmacy over the August–October 2024
Putri Meilisa +6 more
doaj +1 more source
WHY NOT THE PHARMACISTS? [PDF]
Journal of the American Medical Association, 1887 Dear Sir: —The late innovation of having a Section of Dentistry at the Ninth International Medical Congress working so well, and the great excellence of the pharmaceutical display, invite the question, Why not have a Section of Pharmacy in the American Medical Association? It is simply raised for discussion, adding the following memoranda: Pharmacy
openaire +2 more sources
BMJ OpenObjectives This study aimed to investigate the association and potential causal relationship between ischaemic stroke/transient ischaemic attack (TIA) and oral anticoagulant (OAC) adherence using Bradford Hill’s criteria and to determine the factors ...
Mark Harrison +5 more
doaj +1 more source
Use of a trigger tool to detect adverse drug reactions in an emergency department
BMC Pharmacology and Toxicology, 2017 Background Although there are systems for reporting adverse drug reactions (ADR), these safety events remain under reported. The low-cost, low-tech trigger tool method is based on the detection of events through clues, and it seems to increase the ...
Silvana Maria de Almeida +5 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, with an overall survival now surpassing 90% in developed countries. However, treatments are not without adverse effects. In this study, we apply the severe toxicity‐free survival (STFS) framework to determine the prevalence of 21 physician‐defined severe ...
Lane Collier +10 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Type 1 plasminogen deficiency (PLGD‐1) is an ultra‐rare autosomal recessive disorder caused by variants in the PLG gene and affects approximately 1.6 individuals per million. The condition is characterized by decreased plasminogen levels and impaired function, resulting in fibrin‐rich lesions on mucous membranes throughout the body.
Charles Nakar +7 more
wiley +1 more source
Preparation and Evaluation of Telmisartan Solid Dispersion as Sublingual Tablets
مجلة كلية الطبBackground: Telmisartan is an antihypertensive angiotensin II receptor antagonist drug commonly used to treat hypertension and renal disease. Based on the Biopharmaceutical Classification System. It’s a Class II poorly soluble drug.
Hiba Ayad Aziz, Entidhar J. Al-Akkam
doaj +1 more source
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, 2015 In this month’s editorial, we present a new way of looking at pharmacy practice change. This work was a collaboration between the artist and the pharmacist to depict what pharmacists are facing in 2015. We are interested in hearing your thoughts on this work. What does it mean to you? Please write to us.
Jesse, Thomas, Ross, Tsuyuki
openaire +2 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT Introduction The use of herbal medical preparation (HMP) is rising among pediatric oncology patients, often to manage treatment‐related symptoms. Their effectiveness remains uncertain, and the risk of herb–drug interactions is underestimated.
Orianne Mahot +6 more
wiley +1 more source